CKPT — Checkpoint Therapeutics Share News
0.000.00%
- $370.71m
- $337.66m
- $0.04m
Checkpoint Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Checkpoint Therapeutics Q2 income from operations USD -16.195 million
Checkpoint Therapeutics Inc expected to post a loss of 78 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baxter International, Johnson & Johnson, Ford Motor
U.S. STOCKS ON THE MOVE-Hasbro, Sweetgreen, Innoviz Technologies
Checkpoint Therapeutics tumbles on stock-and-warrants offering
Brief: Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results Demonstrating Substantial Increases In Complete Response Rates In Advanced Cutaneous Squamous Cell Carcinoma
Brief: Checkpoint Therapeutics Announces $10 Mln Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
Checkpoint Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Checkpoint Therapeutics Inc - QTRLY Loss Per Share $0.89
Checkpoint Therapeutics Inc expected to post a loss of $1.07 a share - Earnings Preview
Checkpoint Therapeutics Inc expected to post a loss of $1.07 a share - Earnings Preview
Brief: Checkpoint In Agreement To Issue, Sell 1.7 Mln Shares At $3.60/Share
Brief: Checkpoint Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Checkpoint Therapeutics Inc expected to post a loss of $1.31 a share - Earnings Preview
Brief: Checkpoint Therapeutics Inc Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
U.S. STOCKS ON THE MOVE-Kroger, Utz, Dexcom
U.S. STOCKS ON THE MOVE-AerCap, Burlington Stores, Salesforce
U.S. STOCKS ON THE MOVE-Apple Inc, Tesla, Best Buy